Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Vizzi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|January 25, 2011
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)Giuseppe Patti, Vincenzo Pasceri, Vincenzo Vizzi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 23, 2022
Comparing Left Internal Mammary Angiography via Right Radial or Femoral Access With a Single-Catheter TechniqueAlessandro Colombo, Maurizio Di Biasi, Vincenzo Vizzi, et al.
Giornale Italiano Di Cardiologia (2006)|May 7, 2021
[A case of concomitant aortic stenosis and aortic arch aneurysm: a combined endovascular approach]Maurizio Di Biasi, Vincenzo Vizzi, Guido Gelpi, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary interventionFabio Mangiacapra, Emanuele Barbato, Giuseppe Patti, et al.
The American Journal of Cardiology|March 30, 2013
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study)Giuseppe Patti, Fabio Mangiacapra, Elisabetta Ricottini, et al.
The American Journal of Cardiology|August 21, 2010
Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary interventionFabio Mangiacapra, Giuseppe Patti, Aaron Peace, et al.
The American Journal of Cardiology|February 11, 2014
Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary interventionFabio Mangiacapra, Ilaria Cavallari, Emanuele Barbato, et al.
Circulation. Cardiovascular Interventions|May 6, 2015
Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk ScoreFabio Mangiacapra, Elisabetta Ricottini, Emanuele Barbato, et al.
The American Journal of Cardiology|April 23, 2013
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial)Giuseppe Patti, Vincenzo Pasceri, Fabio Mangiacapra, et al.
JACC. Cardiovascular Interventions|March 24, 2012
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) studyFabio Mangiacapra, Giuseppe Patti, Emanuele Barbato, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|January 25, 2011
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)Giuseppe Patti, Vincenzo Pasceri, Vincenzo Vizzi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 23, 2022
Comparing Left Internal Mammary Angiography via Right Radial or Femoral Access With a Single-Catheter TechniqueAlessandro Colombo, Maurizio Di Biasi, Vincenzo Vizzi, et al.
Giornale Italiano Di Cardiologia (2006)|May 7, 2021
[A case of concomitant aortic stenosis and aortic arch aneurysm: a combined endovascular approach]Maurizio Di Biasi, Vincenzo Vizzi, Guido Gelpi, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary interventionFabio Mangiacapra, Emanuele Barbato, Giuseppe Patti, et al.
The American Journal of Cardiology|March 30, 2013
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study)Giuseppe Patti, Fabio Mangiacapra, Elisabetta Ricottini, et al.
The American Journal of Cardiology|August 21, 2010
Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary interventionFabio Mangiacapra, Giuseppe Patti, Aaron Peace, et al.
The American Journal of Cardiology|February 11, 2014
Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary interventionFabio Mangiacapra, Ilaria Cavallari, Emanuele Barbato, et al.
Circulation. Cardiovascular Interventions|May 6, 2015
Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk ScoreFabio Mangiacapra, Elisabetta Ricottini, Emanuele Barbato, et al.
The American Journal of Cardiology|April 23, 2013
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial)Giuseppe Patti, Vincenzo Pasceri, Fabio Mangiacapra, et al.
JACC. Cardiovascular Interventions|March 24, 2012
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) studyFabio Mangiacapra, Giuseppe Patti, Emanuele Barbato, et al.
Pageof 2